Publication:
Importance of glycogen phosphorylase isoenzyme BB, total sialic acid, oxidant and antioxidant parameters in the noninvasive assessment of thrombolytic therapy

dc.contributor.buuauthorSerdar, Zehra
dc.contributor.buuauthorAltın, Aysun
dc.contributor.buuauthorSerdar, Akın
dc.contributor.buuauthorBilgili, Gökhan
dc.contributor.buuauthorDoğruk, Elif Emre
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentBiyokimya Ana Bilim Dalı
dc.contributor.departmentKardiyoloji Ana Bilim Dalı
dc.contributor.orcid0000-0002-0909-618X
dc.contributor.researcheridAAH-6200-2021
dc.contributor.scopusid57222002284
dc.contributor.scopusid17134032300
dc.contributor.scopusid6603403111
dc.contributor.scopusid35077543700
dc.contributor.scopusid55355828300
dc.date.accessioned2022-04-07T06:47:41Z
dc.date.available2022-04-07T06:47:41Z
dc.date.issued2012
dc.description.abstractObjective: The aim of this study was to investigate the effect of thrombolytic therapy on oxidant and antioxidant parameters and glycogen phosphorylase isoenzyme BB (GPBB) concentrations in patients with acute myocardial infarction (AMI). Material and Method: This was a prospective study at an urban academic hospital. We enrolled non-traumatized patients arriving at the emergency department within 3 hours after the onset of chest pain suggestive of AMI. The diagnosis of AMI was established according to clinical features, electrocardiographic findings and increased biochemistry cardiac marker levels. The study was carried out on a total of 75 patients with AMI (50 patients received thrombolytic therapy and 25 patients did not receive thrombolytic therapy), and 45 controls. Blood samples were collected before, and, 2 and 24 hours after tissue-type plasminogen activator therapy Serum malondialdehyde (MDA) and vitamin E were analyzed by high-performance liquid chromatography. Serum total sialic acid and other oxidant and antioxidant parameters were studied spectrophotometrically. Determination of GPBB concentration is based on immunoenzymometric assay. Results: Successful reperfusion was followed by increased serum MDA, protein carbonyls, total sialic acid and GPBB concentrations and by decreased antioxidant vitamins and enzymes. Conclusion: These findings indicate the significance free radical generation processes in reperfusion injury in AMI patients, and suggest the potential involvement of antioxidants in the management of AMI treated by thrombolysis. Also, these parameters especially GPBB can be used for the noninvasive assessment of the effectiveness of thrombolytic therapy.
dc.identifier.citationSerdar, Z. vd. (2012). "Importance of glycogen phosphorylase isoenzyme BB, total sialic acid, oxidant and antioxidant parameters in the noninvasive assessment of thrombolytic therapy". Nobel Medicus, 8(3), 32-39.
dc.identifier.endpage39
dc.identifier.issn1305-2381
dc.identifier.issue3
dc.identifier.scopus2-s2.0-84872975642
dc.identifier.startpage32
dc.identifier.urihttps://www.nobelmedicus.com/Content/1/24/32-39.pdf
dc.identifier.urihttp://hdl.handle.net/11452/25619
dc.identifier.volume8
dc.identifier.wos000312928700006
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherNobel İlaç
dc.relation.journalNobel Medicus
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectGeneral & internal medicine
dc.subjectThrombolytic therapy
dc.subjectGlycogen phosphorylase isoenzyme bb
dc.subjectSialic acid
dc.subjectParaoxonase
dc.subjectMalondialdehyde
dc.subjectSerum paraoxonase arylesterase
dc.subjectCoronary-heart-disease
dc.subjectVitamin-e
dc.subjectLipid-peroxidation
dc.subjectOxidative stress
dc.subjectPlasma malondialdehyde
dc.subjectCardiovascular-disease
dc.subjectMyocardial-ischemia
dc.subjectBiochemical markers
dc.subjectTroponin-t
dc.subject.emtreeAlpha tocopherol
dc.subject.emtreeAlteplase
dc.subject.emtreeFibrinolytic agent
dc.subject.emtreeGlycogen phosphorylase b
dc.subject.emtreeGlycogen phosphorylase isoenzyme bb
dc.subject.emtreeMalonaldehyde
dc.subject.emtreeSialic acid
dc.subject.emtreeUnclassified drug
dc.subject.emtreeAcute heart infarction
dc.subject.emtreeAdult
dc.subject.emtreeAged
dc.subject.emtreeArticle
dc.subject.emtreeBlood clot lysis
dc.subject.emtreeCardiovascular risk
dc.subject.emtreeDisease marker
dc.subject.emtreeElectrocardiography
dc.subject.emtreeEmergency ward
dc.subject.emtreeFemale
dc.subject.emtreeFibrinolytic therapy
dc.subject.emtreeHigh performance liquid chromatography
dc.subject.emtreeHuman
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeNon invasive procedure
dc.subject.emtreePharmacological parameters
dc.subject.emtreeProspective study
dc.subject.emtreeThorax pain
dc.subject.scopusSialic Acids; Glycoconjugates; Fucose
dc.subject.wosMedicine, general & internal
dc.titleImportance of glycogen phosphorylase isoenzyme BB, total sialic acid, oxidant and antioxidant parameters in the noninvasive assessment of thrombolytic therapy
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Biyokimya Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Kardiyoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Serdar_vd_2012.pdf
Size:
2 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: